scispace - formally typeset
C

Cristina Tassorelli

Researcher at University of Pavia

Publications -  406
Citations -  19055

Cristina Tassorelli is an academic researcher from University of Pavia. The author has contributed to research in topics: Migraine & Medicine. The author has an hindex of 50, co-authored 346 publications receiving 15732 citations. Previous affiliations of Cristina Tassorelli include University of Rochester Medical Center & UniFi.

Papers
More filters
Journal ArticleDOI

Assessing and treating primary headaches and cranio-facial pain in patients undergoing rehabilitation for neurological diseases.

TL;DR: This narrative review describes the available literature that has been evaluated in order to define the recommendations and outline the needs of epidemiological studies concerning headache and other cranio-facial pain in neurorehabilitation.
Journal ArticleDOI

The Headache Under-Response to Treatment (HURT) Questionnaire: Assessment of utility in headache specialist care:

TL;DR: It is concluded that the HURT Questionnaire has utility across headache disorders and may guide physicians in assessment of disability of individual patients, how to proceed with management towards the best possible outcome, and in evaluating the quality of management.
Journal ArticleDOI

Alexithymia in chronic and episodic migraine: a comparative study.

TL;DR: Alexithymia emerges as a potential characteristic trait of migraine, regardless of disease severity, even if CM sufferers reported a trend towards higher scores in each TAS factor as well as in TAS total.
Journal ArticleDOI

Focus on therapy of the Chapter IV headaches provoked by exertional factors: primary cough headache, primary exertional headache and primary headache associated with sexual activity.

TL;DR: In this short review, the possible treatment strategies on the basis of information collected from a systematic analysis of the international literature are illustrated.
Journal ArticleDOI

Non-invasive vagus nerve stimulation for primary headache: A clinical update.

TL;DR: Significant progress over the past several years has yielded valuable mechanistic and clinical evidence that suggests that nVNS should be considered a first-line treatment for both acute and preventive treatment of cluster headache, an effective option for acute treatment of migraine, and a highly relevant, practical option for migraine prevention.